Zogenix to Announce New Data at 72nd American Epilepsy Society Annual Meeting
Full Results from Second Pivotal Phase 3 Trial of FINTEPLA® (ZX008) in Dravet Syndrome (Study 1504) New Long-Term Efficacy and […]
Evelo Biosciences Announces First Dosing in Phase 1b Clinical Trial of EDP1815 in Psoriasis and Atopic Dermatitis
Data Expected in Second Half of 2019 CAMBRIDGE, Mass., Nov. 26, 2018 (GLOBE NEWSWIRE) — Evelo Biosciences, Inc. (NASDAQ:EVLO) (“Evelo”) […]
Highway Holdings Reports Fiscal 2019 Second Quarter Results
HONG KONG, Nov. 26, 2018 (GLOBE NEWSWIRE) — Highway Holdings Limited (Nasdaq: HIHO) today reported results for its fiscal 2019 […]
Axovant Stengthens Team with Additional Expertise to Support Gene Therapy Pipeline
Greg MacMichael, Ph.D., formerly global head of cell and gene therapy technical development and manufacturing at Novartis, joins Axovant as […]
Wingstop Begins National Delivery Rollout in Partnership with DoorDash
Wingstop and DoorDash Announce City-By-City Giveaways, starting with Los Angeles, Houston DALLAS, Nov. 26, 2018 (GLOBE NEWSWIRE) — Today, Wingstop […]
CareDx Announces Full Repayment of its Outstanding Debt
Recent Equity Financing Leads to Strong, Debt-Free Balance Sheet BRISBANE, Calif., Nov. 26, 2018 (GLOBE NEWSWIRE) — CareDx, Inc. (NASDAQ: CDNA), […]
Inovio Further Demonstrates Potency of its DNA-Encoded Monoclonal Antibody (dMAb™) Platform in Three Preclinical Publications and Prepares for First Clinical Trial in Early 2019
PLYMOUTH MEETING, Pa., Nov. 26, 2018 (GLOBE NEWSWIRE) — Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today that three recent published […]
Tyme Announces the Presentation of Clinical Abstracts at the 2019 Gastrointestinal Cancers Symposium
NEW YORK, Nov. 26, 2018 (GLOBE NEWSWIRE) — Tyme Technologies, Inc. (NASDAQ: TYME), a clinical-stage oncology company developing metabolically-based cancer therapeutics, […]
Oncolytics Biotech® Announces First Patient Treated in Phase 2 Study Combining Pelareorep and Keytruda® in Advanced Pancreatic Cancer
CALGARY, Alberta and SAN DIEGO, Nov. 26, 2018 (GLOBE NEWSWIRE) — Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), currently developing […]
NV5 Announces Fire Mitigation Contracts totaling $28 Million
HOLLYWOOD, Fla., Nov. 26, 2018 (GLOBE NEWSWIRE) — NV5 Global, Inc. (Nasdaq: NVEE) (“NV5” or the “Company”), a professional engineering […]
